The Mortality Risk of Deferring Optimal Medical Therapy in Heart Failure: A Systematic Comparison Against Norms for Surgical Consent and Patient Information Leaflets

European Journal of Heart Failure - United States
doi 10.1002/ejhf.838
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Medical Therapy of Heart Failure

2016English

Medical Therapy Optimization of Advanced Heart Failure in a Cancer Patient: When to Quit?

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Analysis of Patient Information Leaflets on Artemisinin-Based Combination Therapy

African Journal of Pharmacy and Pharmacology
2018English

Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Costa Rica

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Optimal Indication and Limitation of Surgical Ventricular Reconstruction for Ischemic Heart Failure

Journal of the Japanese Coronary Association
2017English

Atrial Fibrillation and the Risk for Myocardial Infarction, All-Cause Mortality and Heart Failure: A Systematic Review and Meta-Analysis

European Journal of Preventive Cardiology
EpidemiologyCardiovascular MedicineCardiology
2017English

Patient Information Leaflets to Reduce Antibiotic Use and Reconsultation Rates in General Practice: A Systematic Review

BMJ Open
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy